Reflux Esophagitis Phase III Study (Initial Treatment)

Clinical trial NCT00633932 · COMPLETED

Trial details

NCT number: NCT00633932
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Reflux Esophagitis

Start date: 2007-12-01
Enrollment: 602

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.